GLOBAL SYNTHETIC BIOSENSORS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• On January 31, 2024, the World Health Organization (WHO) and the Medicines Patent Pool (MPP), a United Nations-backed public health organization, announced a license agreement with SD Biosensor Inc., a global in-vitro diagnostic company, to grant sublicensee the right, know-how, and materials to manufacture SDB's rapid diagnostic testing (RDT) technology
• In August 2023, IdentifySensors Biologics, a leading developer of digital diagnostic technologies, partnered with U.S.-based, East West Manufacturing, a global engineering and manufacturing services company, to create medical diagnostic devices capable of rapidly detecting and distinguishing multiple infections from a single saliva sample. The testing platform employs printed solid-state electronic biosensors designed to quickly detect pathogen DNA and RNA in saliva samples.
• In April 2022, FREDsense Technologies Corp, a next-generation water quality platform firm, and Ginkgo Bioworks, the leading horizontal platform for cell programming, announced a partnership to develop biosensors for water quality monitoring and detection. Through this partnership, Ginkgo Bioworks seeks to create four separate microbial strain biosensors that are compatible with FREDsense Technologies Corp's field-ready hardware for remote water quality monitoring applications.
• In May 2020, Royal Philips, a global leader in health technology, announced that it has acquired 510(k) approval from the U.S. Food and Drug Administration (FDA) for its wearable biosensor (Philips Biosensor BX100) to help manage proven and suspected COVID-19 patients in the hospital